Sharon Mates

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Hayward, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Lana Gladstein, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Sharon Mates

Form 4 holding Chairman and CEO, Director

Intra-Cellular Therapies, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
02 Apr 2025
Price
$132.00
Ownership
By the Sharon Mates Family Foundation
Form 4 holding Chairman and CEO, Director

Intra-Cellular Therapies, Inc.

Security class
Performance Stock Units
Shares / value
0
Estimated value
$0
Report date
02 Apr 2025
Price
$132.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman and CEO, Director

Intra-Cellular Therapies, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
02 Apr 2025
Price
$132.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Seaport Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
49,033
Estimated value
Report date
30 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman and CEO, Director

Intra-Cellular Therapies, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
02 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sharon Mates

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .